TET2 and cyclic hematopoiesis: Heterozygous tet methylcytosine dioxygenase 2 (TET2) and DNA methyltransferase 3A (DNMT3A) mutations are the two most frequent drivers of CH1, and mechanistic studies connecting CH and CVD revolve around Tet2-deficient models.